Back to Trials
NCT06762795NARecruiting

The HIEnome Study: Genome Sequencing for Perinatal HIE

Baylor College of Medicine

Start Date

5/15/2025

Completion Date

6/30/2027

Summary

Perinatal hypoxic-ischemic encephalopathy is a rare severe condition in which neonates present with encephalopathy and a clinical history suggestive of prenatal or perinatal hypoxic-ischemic injury. Emerging evidence suggests that genetic conditions are frequently identified in cases of perinatal HIE; however, it is unclear which neonates with this diagnosis warrant genetic testing. This study will offer clinical genome sequencing to neonates with HIE who are undergoing total body cooling (therapeutic hypothermia) and their parents.

Eligibility Criteria

Age Range: No minimum to 1 years

Inclusion Criteria: * Delivery ≥35w0d gestation * Diagnosed with moderate or severe HIE, or HIE with seizures * Undergoing total body cooling / therapeutic hypothermia * Able to provide blood or buccal samples during birth hospitalization * Admitted to Texas Children's Hospital Main, West, or Woodlands NICU Exclusion Criteria: * Parents/family not willing to allow participation * Inability to collect sufficient neonatal blood samples (in some circumstances, a buccal swab may be used as backup)

Interventions

GENETIC

Genome sequencing

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hypoxic Ischemic Encephalopathy of NewbornHypoxic Ischemic EncephalopathyHypoxic Ischemic Encephalopathy (HIE)

Locations

Texas Children's Hospital

Houston, Texas 77030

United States

Texas Children's Hospital

Houston, Texas 77030

United States